ADNRX Fund Portfolio Allocation
General Overview
Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are principally in developed markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The fund is non-diversified.
Sector & Industry | Financial Services / Asset Management |
IPO date | October 29, 2020 |
ADNRX Latest News
|
|
|
|
|
Other Identifiers | |
---|---|
CIK | 0000809593 |
ISIN | None |
CUSIP | None |
Open | 19.58 |
Previous Close | 19.4 |
Volume | 0 |
Average Volume | 0 |
Day’s Range | 19.58 – 19.58 |
52 Week Range | 10.87-19.58 |
MA (50) | 16.2456 |
MA (200) | 15.1428 |
Market Cap | 171.3 Mil. |
Shares Out. | 8.75 Mil. |
Earnings Date | |
Beta | |
Last Dividend | |
EPS | |
PE | |